Factor VIII in Monkeys, Effect of DDAVP Analogues

[1]  T. Barth,et al.  Plasma concentrations of factor VIII after administration of DDAVP to conscious dogs. , 1987, Thrombosis research.

[2]  J. Lusher,et al.  DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease. , 1983, The Journal of pediatrics.

[3]  D. Becker,et al.  1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood. , 1978, The Journal of pediatrics.

[4]  P. Richards,et al.  Desmopressin urine concentration test. , 1978, British medical journal.

[5]  P. Mannucci,et al.  Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs , 1975, British journal of haematology.

[6]  Cash Jd,et al.  Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man. , 1974 .

[7]  F. Šorm,et al.  Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus. , 1968, Lancet.

[8]  H. Schild.  pAx and competitive drug antagonism. , 1949, British journal of pharmacology and chemotherapy.

[9]  T. Barth,et al.  Structure-activity relationships of vasopressin analogues on release of factor VIII in dogs. , 1991, Journal of receptor research.

[10]  T. Barth,et al.  Prolonged antidiuretic action of vasopressin analogues in relation to their primary structure , 1981 .

[11]  F. Šorm,et al.  Amino acids and peptides. LXXI. Synthesis of 1-deamino-8-D-γ-aminobutyrine-vasopressin, 1-deamino-8-D-lysine-vasopressin, and 1-deamino-8-D-arginine-vasopressin , 1967 .